MedTrace Logo

Samsca Post Marketing Surveillance Study

NCT02722863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 908

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

This Post-Marketing Surveillance will be conducted in accordance with the local regulation of New Drug Re-examination. The surveillance will be conducted for 6 years of the re-examination period (01Sep2011\~31Aug2017). Each subject will be observed at least for 4 days during the surveillance period.

Conditions

  • Hypervolemic and Euvolemic Hyponatremia

Sponsors & Collaborators

  • Korea Otsuka Pharmaceutical Co., Ltd.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-09
Primary Completion
2017-06-15
Completion
2017-06-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02722863 on ClinicalTrials.gov